Anna Enjuanes

6.6k total citations
36 papers, 1.1k citations indexed

About

Anna Enjuanes is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Anna Enjuanes has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Anna Enjuanes's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Bone health and treatments (6 papers). Anna Enjuanes is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Bone health and treatments (6 papers). Anna Enjuanes collaborates with scholars based in Spain, Germany and United Kingdom. Anna Enjuanes's co-authors include Adolfo Díez‐Pérez, Xavier Nogués, Leonardo Mellibovsky, Susana Balcells, Daniel Grinberg, Elı́as Campo, Sílvia Ruiz-Gaspà, Natalia García‐Giralt, Ramón Carreras and Pedro Jares and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Anna Enjuanes

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Enjuanes Spain	21	373	365	330	241	203	36	1.1k
Batia Avni Israel	19	419 1.1×	243 0.7×	449 1.4×	134 0.6×	300 1.5×	66	1.4k
Miguel Alcoceba Spain	21	322 0.9×	439 1.2×	442 1.3×	121 0.5×	460 2.3×	79	1.3k
Ryuichi Kamiyama Japan	24	548 1.5×	384 1.1×	435 1.3×	61 0.3×	270 1.3×	75	1.8k
Toshifumi Sugatani United States	20	1.1k 2.9×	161 0.4×	415 1.3×	234 1.0×	52 0.3×	27	2.1k
Detlef Haase Germany	23	1.0k 2.8×	274 0.8×	346 1.0×	99 0.4×	1.1k 5.3×	101	3.1k
Nora Viniou Greece	15	339 0.9×	188 0.5×	489 1.5×	73 0.3×	321 1.6×	43	1.1k
Danielle Diarra Austria	10	671 1.8×	129 0.4×	390 1.2×	484 2.0×	65 0.3×	14	1.7k
Kamel Laribi France	17	336 0.9×	329 0.9×	606 1.8×	86 0.4×	321 1.6×	62	1.2k
Fılız Bolat Türkiye	18	213 0.6×	203 0.6×	219 0.7×	65 0.3×	37 0.2×	80	1.1k
Jan M. Van Tornout United States	10	693 1.9×	263 0.7×	382 1.2×	174 0.7×	43 0.2×	16	1.2k

Countries citing papers authored by Anna Enjuanes

Since Specialization

Citations

This map shows the geographic impact of Anna Enjuanes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Enjuanes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Enjuanes more than expected).

Fields of papers citing papers by Anna Enjuanes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Enjuanes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Enjuanes. The network helps show where Anna Enjuanes may publish in the future.

Co-authorship network of co-authors of Anna Enjuanes

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Enjuanes. A scholar is included among the top collaborators of Anna Enjuanes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Enjuanes. Anna Enjuanes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martı́n, Alejandro, Mónica Baile, Guillermo Rodríguez‐Domínguez, et al.. (2023). Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from GELTAMO. British Journal of Haematology. 203(2). 202–211.

Frigola, Gerard, Marco M. Bühler, Anna Enjuanes, et al.. (2022). MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas. Archives of Pathology & Laboratory Medicine. 147(8). 896–906. 6 indexed citations

Demajo, Santiago, Guillem Clot, Giancarlo Castellano, et al.. (2020). A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma. Clinical Cancer Research. 27(1). 213–225. 10 indexed citations

Croci, Giorgio Alberto, Eva Hoster, Sı́lvia Beà, et al.. (2020). Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(2). 259–267. 9 indexed citations

Rovira, Jordina, Kennosuke Karube, Alexandra Valera, et al.. (2016). MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome. Clinical Cancer Research. 22(11). 2755–2764. 50 indexed citations

Corbera‐Bellalta, Marc, Ester Planas‐Rigol, Ester Lozano, et al.. (2015). Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis. Annals of the Rheumatic Diseases. 75(6). 1177–1186. 95 indexed citations

Martín‐Guerrero, Idoia, Anna Enjuanes, Julia Richter, et al.. (2011). A putative “hepitype” in the ATM gene associated with chronic lymphocytic leukemia risk. Genes Chromosomes and Cancer. 50(11). 887–895. 3 indexed citations

Crowther-Swanepoel, Dalemari, Mahmoud Mansouri, Anna Enjuanes, et al.. (2010). Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk. British Journal of Haematology. 150(4). 473–479. 30 indexed citations

Enjuanes, Anna, Sílvia Ruiz-Gaspà, Pilar Peris, et al.. (2010). The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. Endocrine. 37(2). 322–328. 16 indexed citations

10.

Ruiz-Gaspà, Sílvia, Núria Guañabens, Pilar Peris, et al.. (2010). Effects of bilirubin and sera from jaundiced patients on osteoblasts: Contribution to the development of osteoporosis in liver diseases. Hepatology. 54(6). 2104–2113. 55 indexed citations

11.

Ruiz-Gaspà, Sílvia, Núria Guañabens, Anna Enjuanes, et al.. (2009). Lithocholic acid downregulates vitamin D effects in human osteoblasts. European Journal of Clinical Investigation. 40(1). 25–34. 56 indexed citations

12.

Guañabens, Núria, Anna Enjuanes, Luisa Álvarez, et al.. (2009). High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue. Journal of Bone and Mineral Metabolism. 27(3). 347–354. 20 indexed citations

13.

Enjuanes, Anna, Yolanda Benavente, Francesc Bosch, et al.. (2008). Genetic Variants in Apoptosis and Immunoregulation-Related Genes Are Associated with Risk of Chronic Lymphocytic Leukemia. Cancer Research. 68(24). 10178–10186. 60 indexed citations

14.

Ruiz-Gaspà, Sílvia, Xavier Nogués, Anna Enjuanes, et al.. (2007). Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG‐63 cultures. Journal of Cellular Biochemistry. 101(6). 1430–1438. 75 indexed citations

15.

Supervía, August, Xavier Nogués, Anna Enjuanes, et al.. (2006). Effect of smoking and smoking cessation on bone mass, bone remodeling, vitamin D, PTH and sex hormones.. PubMed. 6(3). 234–41. 50 indexed citations

16.

Bustamante, Mariona, Xavier Nogués, Anna Enjuanes, et al.. (2006). COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women. Osteoporosis International. 18(2). 235–243. 49 indexed citations

17.

Enjuanes, Anna, Natalia García‐Giralt, August Supervía, et al.. (2005). A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women. Bone. 38(5). 738–743. 20 indexed citations

18.

Enjuanes, Anna, Natalia García‐Giralt, August Supervía, et al.. (2005). Functional analysis of the I.3, I.6, pII and I.4 promoters of CYP19 (aromatase) gene in human osteoblasts and their role in vitamin D and dexamethasone stimulation. European Journal of Endocrinology. 153(6). 981–988. 23 indexed citations

19.

Enjuanes, Anna, Natalia García‐Giralt, August Supervía, et al.. (2003). Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments. European Journal of Endocrinology. 148(5). 519–526. 49 indexed citations

20.

Enjuanes, Anna, et al.. (1997). Prevalencia de tabaquismo en 6 comarcas de Lleida. Medicina Clínica. 19(5). 221–225. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact